Search - tctmd.com

Displaying 901 - 920 of 2223

Sort: Relevancy | Date

Presentation TCT 2016

Trial #5 - The Essentials of TOTAL - One-Year Outcomes of Aspiration in STEMI

Presenter: Sunil V. Rao, Harvey D. White, Warren J. Cantor

October 31, 2016

Presentation TCT 2016

Site-reported vs Core Lab Syntax Scores: Discordance and Impact on Outcomes After PCI vs CABG in EXCEL

Presenter: A. Pieter Kappetein, Marie-Claude Morice, Philippe Généreux

October 31, 2016

Presentation TCT 2016

STICH and STICHES Critique: Pros and Cons

Presenter: Sunil V. Rao, Harvey D. White, James E. Udelson

October 31, 2016

Presentation TCT 2016

Trial #4 - The Essentials of ... STICH and STICHES - Ten-Year Follow-up

Presenter: Sunil V. Rao, Harvey D. White, Robert A. Guyton

October 31, 2016

Presentation TCT 2016

LEADERS FREE: Pros and Cons

Presenter: Sunil V. Rao, Harvey D. White, Donald Cutlip

October 31, 2016

Presentation TCT 2016

Trial #3 - The Essentials of ... the LEADERS FREE trial

Presenter: Sunil V. Rao, Harvey D. White, Philip M. Urban

October 31, 2016

Presentation TCT 2016

Making Sense: From Risk Scores to Triage Left Main Patients to PCI vs CABG

Presenter: Seung-Jung Park, Leif Thuesen, Davide Capodanno

October 31, 2016

Presentation TCT 2016

MATRIX Critique: Pros and Cons

Presenter: Sunil V. Rao, Harvey D. White, Frederick Feit

October 31, 2016

Presentation TCT 2016

Trial #2 - The Essentials of ... the MATRIX Trial Access Site and Anticoagulation Type (And Infusion Duration) in ACS

Presenter: Sunil V. Rao, Harvey D. White, Salvatore Brugaletta

October 31, 2016

Presentation TCT 2016

ABSORB III Critique: Pros and Cons

Presenter: Sunil V. Rao, Harvey D. White, Ron Waksman

October 31, 2016

Presentation TCT 2016

Trial #1 - The Essentials of ... ABSORB III Everolimus-Eluting Bioresorbable Vascular Scaffolds vs Everolimus-Eluting Metallic Stents in Coronary Artery Disease

Presenter: Sunil V. Rao, Harvey D. White, Stephen G. Ellis

October 31, 2016

Presentation TCT 2016

Left Main PCI vs CABG From the Asan Medical Center: Insights Into Patient Selection and Technique to Optimize Outcomes

Presenter: Seung-Jung Park, Leif Thuesen

October 31, 2016

News Industry News

Study Indicates That Open Heart Surgery May Be Superior To PCI For Treatment Of Left Main Coronary Artery Disease

October 31, 2016

News Industry News

Trial Results Suggest That Drug-Eluting Stents Are Acceptable Alternative To Open Heart Surgery For Select Patients With Left Main Coronary Artery Disease

October 31, 2016

News Conference News TCT 2016

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

EXCEL 和 NOBLE：左主干 PCI/CABG 的选择结果相悖

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

EXCEL y NOBLE: Los Resultados Contrarios Plantean un Dilema a la Hora de Elegir entre PCI y CABG en el Manejo de la Enfermedad de Tronco Coronario Izdo.

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Michael O'Riordan

October 31, 2016

Presentation TCT 2016

Canada Presents: CABG vs PCI in Left Main Disease

Presenter: Thomas Engstroem, Hyo-Soo Kim, Samer Mansour, Quang Ngoc Nguyen

October 30, 2016

Presentation TCT 2016

Debate: PCI vs CABG for Left Main Disease - CABG Is and Remains the Gold Standard!

Presenter: Russell A. Brandwein, Robert A. Guyton

October 30, 2016

Advertisement

Trial #5 - The Essentials of TOTAL - One-Year Outcomes of Aspiration in STEMI

Site-reported vs Core Lab Syntax Scores: Discordance and Impact on Outcomes After PCI vs CABG in EXCEL

STICH and STICHES Critique: Pros and Cons

Trial #4 - The Essentials of ... STICH and STICHES - Ten-Year Follow-up

LEADERS FREE: Pros and Cons

Trial #3 - The Essentials of ... the LEADERS FREE trial

Making Sense: From Risk Scores to Triage Left Main Patients to PCI vs CABG

MATRIX Critique: Pros and Cons

Trial #2 - The Essentials of ... the MATRIX Trial Access Site and Anticoagulation Type (And Infusion Duration) in ACS

ABSORB III Critique: Pros and Cons

Trial #1 - The Essentials of ... ABSORB III Everolimus-Eluting Bioresorbable Vascular Scaffolds vs Everolimus-Eluting Metallic Stents in Coronary Artery Disease

Left Main PCI vs CABG From the Asan Medical Center: Insights Into Patient Selection and Technique to Optimize Outcomes

Study Indicates That Open Heart Surgery May Be Superior To PCI For Treatment Of Left Main Coronary Artery Disease

Trial Results Suggest That Drug-Eluting Stents Are Acceptable Alternative To Open Heart Surgery For Select Patients With Left Main Coronary Artery Disease

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

EXCEL 和 NOBLE：左主干 PCI/CABG 的选择结果相悖

EXCEL y NOBLE: Los Resultados Contrarios Plantean un Dilema a la Hora de Elegir entre PCI y CABG en el Manejo de la Enfermedad de Tronco Coronario Izdo.

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Canada Presents: CABG vs PCI in Left Main Disease

Debate: PCI vs CABG for Left Main Disease - CABG Is and Remains the Gold Standard!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content